Standard Dental Labs Inc. Announces Strategic Corporate Updates

Key Takeaways:

• Standard Dental Labs Inc. changes its name from Costas, Inc. and updates its ticker symbol to “TUTH.”
• A 20:1 reverse stock split is effective March 13, 2025, with post-split trading starting March 14.
• The company aims to enhance its market position and investor appeal through these strategic moves.
• No fractional shares will be issued; all fractional shares will be rounded up to the nearest whole share.
• Transfer Online, Inc. will manage the stock exchange process for shareholders.

Corporate Rebranding Reflects Strategic Growth Focus

Standard Dental Labs Inc. (OTCMKTS: TUTH), a prominent player in the dental prosthetics sector, has officially rebranded itself following FINRA’s approval of its name change from Costas, Inc. This rebranding aligns with the company’s broader strategy to solidify its presence in the dental industry and streamline operations. Alongside the name change, SDL’s ticker symbol will transition from “CSSI” to “TUTH,” effective April 10, 2025.

The decision to rebrand comes as SDL continues to expand its footprint by acquiring and integrating private dental labs, particularly in Florida. According to the company’s CEO, James Brooks, “This marks an exciting milestone for Standard Dental Labs. The FINRA approval and stock split reflect our commitment to advancing SDL’s market position while continuing to execute our strategy of acquiring and integrating dental labs.”

Reverse Stock Split Aims to Optimize Share Structure

In conjunction with the rebranding, SDL has implemented a reverse stock split at a ratio of 20 old shares for 1 new share. The split became effective on March 13, 2025, at 11:59 p.m. Pacific Standard Time, with trading on a split-adjusted basis commencing on March 14, 2025.

This move is intended to optimize the company’s stock structure and improve its attractiveness to investors. While the authorized capital remains unchanged at 2,000,000,000 shares, the number of issued and outstanding shares will decrease significantly. As of March 13, 2025, SDL had approximately 572,206,363 shares outstanding, which will consolidate to about 28,610,318 shares post-split.

To ensure smooth execution, the company’s transfer agent, Transfer Online, Inc., will oversee the exchange process. Shareholders holding shares in certificated form are not required to exchange their existing certificates but may do so if desired. For those holding shares in “street name,” brokers will provide necessary instructions.

Implications for Shareholders and Outstanding Securities

The reverse stock split will also impact outstanding securities, including options, restricted stock awards, warrants, preferred stock, and convertible notes. These instruments will be adjusted proportionally, with the number of acquirable shares decreasing by the 20:1 ratio and exercise or conversion prices increasing accordingly.

Notably, no fractional shares will be issued as part of the split. Instead, fractional shares will be rounded up to the nearest whole share, ensuring that all shareholders receive equitable treatment.

Strategic Vision for the Future

SDL’s leadership emphasizes its dedication to transforming the dental lab industry through technological innovation and operational efficiency. By focusing on acquisitions and integration, the company seeks to expand its capabilities and deliver high-quality, custom dental prosthetics.

Florida remains a critical market for SDL, where it continues to strengthen its position as a leading provider of dental solutions. The company’s forward-looking approach underscores its commitment to delivering value to both shareholders and partners.